Header Logo

Connection

Xavier Keutgen to Neuroendocrine Tumors

Back to Details
This is a "connection" page, showing publications Xavier Keutgen has written about Neuroendocrine Tumors.
Xavier Keutgen
Connection Strength
10.291
Neuroendocrine Tumors
  1. Loss of MEN1 function impairs DNA repair capability of pancreatic neuroendocrine tumors. Endocr Relat Cancer. 2022 03 21; 29(4):225-239.
    View in: PubMed
    Score: 0.743
  2. First Differentiate and Then Operate (Or Not) : Editorial on "Surgical Treatment of Patients with Poorly Differentiated Pancreatic Neuroendocrine Carcinoma: An NCDB Analysis". Ann Surg Oncol. 2022 06; 29(6):3371-3372.
    View in: PubMed
    Score: 0.740
  3. Sunitinib-Loaded Chondroitin Sulfate Hydrogels as a Novel Drug-Delivery Mechanism for the Treatment of Pancreatic Neuroendocrine Tumors. Ann Surg Oncol. 2021 Dec; 28(13):8532-8543.
    View in: PubMed
    Score: 0.703
  4. Response rates in metastatic neuroendocrine tumors receiving peptide receptor radionuclide therapy and implications for future treatment strategies. Surgery. 2021 01; 169(1):162-167.
    View in: PubMed
    Score: 0.654
  5. Surgical Management of Pancreatic Neuroendocrine Tumors. Surg Oncol Clin N Am. 2020 Apr; 29(2):243-252.
    View in: PubMed
    Score: 0.648
  6. Should 68Ga-DOTATATE PET/CT be Performed Routinely in Patients with Neuroendocrine Tumors Before Surgical Resection? World J Surg. 2020 02; 44(2):604-611.
    View in: PubMed
    Score: 0.641
  7. Operative resection in early stage pancreatic neuroendocrine tumors in the United States: Are we over- or undertreating patients? Surgery. 2020 01; 167(1):180-186.
    View in: PubMed
    Score: 0.624
  8. Do All Abdominal Neuroendocrine Tumors Require Extended Postoperative VTE Prophylaxis? A NSQIP Analysis. J Gastrointest Surg. 2019 04; 23(4):788-793.
    View in: PubMed
    Score: 0.597
  9. 68Gallium-DOTATATE positron emission tomography-computed tomography (PET CT) changes management in a majority of patients with neuroendocrine tumors. Surgery. 2019 01; 165(1):178-185.
    View in: PubMed
    Score: 0.588
  10. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors. Surgery. 2019 03; 165(3):644-651.
    View in: PubMed
    Score: 0.586
  11. Metastatic neuroendocrine tumors of the gastrointestinal tract and pancreas: A surgeon's plea to centering attention on the liver. Semin Oncol. 2018 08; 45(4):232-235.
    View in: PubMed
    Score: 0.585
  12. Reoperative Surgery in Patients with Multiple Endocrine Neoplasia Type 1 Associated Primary Hyperparathyroidism. Ann Surg Oncol. 2016 12; 23(Suppl 5):701-707.
    View in: PubMed
    Score: 0.502
  13. Malignant-functioning neuroendocrine tumors of the pancreas: A survival analysis. Surgery. 2016 May; 159(5):1382-9.
    View in: PubMed
    Score: 0.481
  14. Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors. Surgery. 2016 Jan; 159(1):311-8.
    View in: PubMed
    Score: 0.475
  15. Number of Hepatic Resections and Association with Complication after Metastatic Neuroendocrine Tumor Debulking: An American College of Surgeons NSQIP Database Study. J Am Coll Surg. 2023 07 01; 237(1):157-168.
    View in: PubMed
    Score: 0.199
  16. Light It Up! The Use of DOTATATE in Diagnosis and Treatment of Neuroendocrine Neoplasms. Surg Pathol Clin. 2023 Mar; 16(1):151-161.
    View in: PubMed
    Score: 0.195
  17. Epigenetic Dysregulation of 5-hydroxymethylcytosine in Well-Differentiated Pancreatic Neuroendocrine Tumors. Appl Immunohistochem Mol Morphol. 2022 02 01; 30(2):e11-e15.
    View in: PubMed
    Score: 0.184
  18. Preoperative serum chromogranin-a is predictive of survival in locoregional jejuno-ileal small bowel neuroendocrine tumors. Surgery. 2021 07; 170(1):106-113.
    View in: PubMed
    Score: 0.174
  19. The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors. Pancreas. 2020 01; 49(1):1-33.
    View in: PubMed
    Score: 0.159
  20. The Role of Perioperative Systemic Therapy in Localized Pancreatic Neuroendocrine Neoplasms. Neuroendocrinology. 2020; 110(3-4):234-245.
    View in: PubMed
    Score: 0.153
  21. ONCOGENE PANEL SEQUENCING ANALYSIS IDENTIFIES CANDIDATE ACTIONABLE GENES IN ADVANCED WELL-DIFFERENTIATED GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS. Endocr Pract. 2019 Jun; 25(6):580-588.
    View in: PubMed
    Score: 0.151
  22. Prognostic Utility of Total 68Ga-DOTATATE-Avid Tumor Volume in Patients With Neuroendocrine Tumors. Gastroenterology. 2018 03; 154(4):998-1008.e1.
    View in: PubMed
    Score: 0.137
  23. Association between neuroendocrine tumors biomarkers and primary tumor site and disease type based on total 68Ga-DOTATATE-Avid tumor volume measurements. Eur J Endocrinol. 2017 May; 176(5):575-582.
    View in: PubMed
    Score: 0.132
  24. Evaluation and management of pancreatic lesions in patients with von Hippel-Lindau disease. Nat Rev Clin Oncol. 2016 09; 13(9):537-49.
    View in: PubMed
    Score: 0.123
  25. Feasibility of Radio-Guided Surgery with 68Gallium-DOTATATE in Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumors. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S676-82.
    View in: PubMed
    Score: 0.118
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.